CJC-1295 DAC is a modified growth hormone releasing hormone (GHRH 1-29) analogue with a Drug Affinity Complex tail that binds to albumin, extending its half-life to roughly 6-8 days versus minutes for native GHRH.
Compared to CJC-1295 without DAC (mod GRF 1-29), the DAC version produces a more sustained GH elevation rather than a sharp pulse. Often stacked with Ipamorelin in informal protocols.
This entry is informational only.